Leveraging decades of experience in the healthcare industry and its subsectors, Simpson Thacher has been the preferred partner for a diverse array of leading companies, investment funds and financial advisors. We guide our clients in navigating the complexities of today’s business, scientific, regulatory and political trends.
Practice Group of the Year
Named a Law360 Health Care “Practice Group of the Year” for 2023
Whether we are advising on multibillion-dollar mergers, tackling major antitrust challenges or guiding clients through disputes and investigations, our healthcare group delivers results through industry-specific experience and leveraging a cross-practice, collaborative team.
We advise our clients on matters involving regulations administered and enforced by the U.S. Food and Drug Administration, the U.S. Department of Health and Human Services, U.S. Drug Enforcement Administration, the U.S. Treasury Department’s Office of Foreign Assets Control, the U.S. State Department, the U.S. Commerce Department’s Bureau of Industry and Security, and state laws and regulations.
We value, and know how to build, successful long-term relationships with our clients and work with them to anticipate challenges so that they can aggressively pursue market and business opportunities.
Our team represents clients across major healthcare and life sciences subsectors. We have recently advised on transactions such as:
We take a holistic approach to partnering with our clients with capabilities to advise on: